Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
AI Echocardiographic Screening of Cardiac Amyloidosis
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Clinical study
0
Allocation Type
NA
0
Trial Collaborator
Northwestern Medicine
0
Participating Facility
Northwestern Medicine
0
Health Conditions in Trial
Cardiac amyloidosis
0
Intervention Model
Single Group Assignment
0
Interventional Trial Phase
Not Applicable
0
Interventional Trial Purpose
Diagnostic
0
Intervention Treatment
EchoNet-LVH Assessment
0
Intervention Type
Diagnostic Test
0
Last Updated
October 31, 2024
0
Masking Type
None (Open Label)
0
Primary Completion Date
November 1, 2025
0
Trial Recruitment Size
500
0
Trial Sponsor
Cedars-Sinai Medical Center
0
Clinical Trial Start Date
October 28, 2024
0
Study Completion Date
November 1, 2026
0
Clinical Trial Study Type
Interventional
0
NCT Number
NCT06664866
0
Official Name
Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)
0
Official Website
clinicaltrials.gov/study...664866
0
Find more entities like AI Echocardiographic Screening of Cardiac Amyloidosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE